Stockscreener 앱 받기
65.37
2.64%
1.68
전일 마감가:
$63.69
열려 있는:
$64.03
하루 거래량:
1.96M
Relative Volume:
0.62
시가총액:
$14.57B
수익:
$4.03B
순이익/손실:
$556.70M
주가수익비율:
27.58
EPS:
2.37
순현금흐름:
$970.10M
1주 성능:
+3.34%
1개월 성능:
+1.38%
6개월 성능:
-8.18%
1년 성능:
-16.60%
1일 변동 폭
$63.92
$65.59
1주일 범위
$63.39
$65.59
52주 변동 폭
$51.90
$84.67
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
HOLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
65.37 | 14.10B | 4.03B | 556.70M | 970.10M | 2.37 |
|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
홀로직 Stock (HOLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-05-27 | 재확인 | Needham | Hold |
| 2025-03-03 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | 다운그레이드 | Needham | Buy → Hold |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-12-10 | 재확인 | Needham | Buy |
| 2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-27 | 개시 | Stephens | Overweight |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-14 | 업그레이드 | Needham | Hold → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-05 | 재확인 | Needham | Buy |
| 2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 재확인 | Needham | Buy |
| 2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-01-31 | 재확인 | Needham | Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
The Bull Case For Hologic (HOLX) Could Change Following Major Debt Refinance and Extended Loan Terms – Learn Why - simplywall.st
Hologic Inc. Stock Analysis and ForecastDynamic growth stocks - Autocar Professional
Is Hologic Inc. a good long term investmentFree Stock Movement Tracking - jammulinksnews.com
Hologic (HOLX) Laps the Stock Market: Here's Why - Yahoo Finance
Hologic Q3 Preview: Tariff Pressure And Undervalued Stock Price, Initiate With Buy (HOLX) - Seeking Alpha
Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report? - The Globe and Mail
Breast Cancer Diagnostic Market Witnesses Growth Due - openPR.com
Unexpected Trends Reshaping the Gynecological Devices Market - openPR.com
What drives Hologic Inc. stock priceBreakthrough investment results - Autocar Professional
What to Expect From Hologic's Q3 2025 Earnings Report - MSN
What analysts say about Hologic Inc. stockSuperior stock growth - PrintWeekIndia
Is Hologic, Inc. (NASDAQ:HOLX) Trading At A 38% Discount? - simplywall.st
Hologic Refinances Loan to Enhance Financial Flexibility - The Globe and Mail
Unexpected Trends Reshaping the Uterine Fibroid (UF) Treatment - openPR.com
Sentinel Node Biopsy Market Future Business Opportunities - openPR.com
Hologic’s SWOT analysis: breast health recovery boosts stock outlook By Investing.com - Investing.com South Africa
Hologic’s SWOT analysis: breast health recovery boosts stock outlook - Investing.com
Cervical Dysplasia Market is Booming Worldwide |Hologic,Qiagen,Advaxis - openPR.com
Mizuho Raises Hologic Price Target to $70, Maintains Outperform Rating - AInvest
Hologic, Inc. (HOLX) Stock Forecasts - Yahoo Finance
Hologic (HOLX) Maintains Outperform Rating, Price Target Raised by Mizuho | HOLX Stock News - GuruFocus
Hologic Rides on AI-Powered Breast Health Innovations: What's Next? - Nasdaq
How the Computer Aided Detection Market Will Evolve by 2032 - openPR.com
Why Hologic (HOLX) Dipped More Than Broader Market Today - Yahoo Finance
Hologic, Inc. Fiscal Q3 2025 Earnings Release and ProjectionsNews and Statistics - IndexBox
Hologic's Q3 2025 Earnings: A Hidden Gem in Medtech Undervaluation - AInvest
Hologic Q3 2025 Earnings Report: Analyst Expectations and Stock Performance - AInvest
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
What makes Hologic Inc. stock price move sharplyDaily Top Gainers - beatles.ru
Hologic Maintains Strength in Diagnostics but Cuts to Medicaid Could Pressure Volume - Morningstar
Global Uterine Fibroids Treatment Devices Market to grow at - openPR.com
Hips & Knees Reconstructive Market Attracts 3D Implant - openPR.com
Hologic's GYN Surgical Dominance: What's Powering The Road Ahead? - Barchart.com
Hologic's GYN Surgical Dominance: What's Powering the Road Ahead? - The Globe and Mail
Hologic (HOLX) Surpasses Market Returns: Some Facts Worth Knowing - Yahoo Finance
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.40%
자본화:
|
볼륨(24시간):